| Ticker Details |
|
Niagen Bioscience, Inc
|
| IPO Date: |
June 25, 2007 |
| Sector: |
Healthcare |
| Industry: |
Biotechnology |
| Market Cap: |
$358.76M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.21 | 2.51%
|
| Avg Daily Range (30 D): |
$0.09 | 1.85%
|
| Avg Daily Range (90 D): |
$0.11 | 1.92%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.87M |
| Avg Daily Volume (30 D): |
1.3M |
| Avg Daily Volume (90 D): |
.88M |
| Trade Size |
| Avg Trade Size (Sh.): |
79 |
| Avg Trade Size (Sh.) (30 D): |
99 |
| Avg Trade Size (Sh.) (90 D): |
87 |
| Institutional Trades |
| Total Institutional Trades: |
216 |
| Avg Institutional Trade: |
$1.07M |
| Avg Institutional Trade (30 D): |
$.96M |
| Avg Institutional Trade (90 D): |
$.92M |
| Avg Institutional Trade Volume: |
.13M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.07M |
| Avg Closing Trade (30 D): |
$.96M |
| Avg Closing Trade (90 D): |
$.9M |
| Avg Closing Volume: |
129.41K |
|
|
| Financials |
| |
TTM |
Q4 2025 |
FY 2025 |
|
Basic EPS
|
$.22
|
$.05
|
$.22
|
|
Diluted EPS
|
$.2
|
$.05
|
$.2
|
|
Revenue
|
$129.42M
|
$33.84M
|
$129.42M
|
|
Gross Profit
|
$83.19M
|
$21.7M
|
$83.19M
|
|
Net Income / Loss
|
$17.38M
|
$4.13M
|
$17.38M
|
|
Operating Income / Loss
|
$16.28M
|
$4.09M
|
$16.28M
|
|
Cost of Revenue
|
$46.23M
|
$12.14M
|
$46.23M
|
|
Net Cash Flow
|
$20.13M
|
$.5M
|
$20.13M
|
|
PE Ratio
|
22.30
|
|
|
| Splits |
|
Dec 07, 2006
|
3.19:1
|
|
|
|
